eicosapentaenoic acid ethyl ester has been researched along with Atrophy in 1 studies
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Puri, BK | 1 |
| Bydder, GM | 1 |
| Counsell, SJ | 1 |
| Corridan, BJ | 1 |
| Richardson, AJ | 1 |
| Hajnal, JV | 1 |
| Appel, C | 1 |
| Mckee, HM | 1 |
| Vaddadi, KS | 1 |
| Horrobin, DF | 1 |
1 trial available for eicosapentaenoic acid ethyl ester and Atrophy
| Article | Year |
|---|---|
MRI and neuropsychological improvement in Huntington disease following ethyl-EPA treatment.
Topics: Aged; Atrophy; Brain; Double-Blind Method; Dyskinesia, Drug-Induced; Eicosapentaenoic Acid; Female; | 2002 |